June 6th 2024
Posters presented at SLEEP 2024 found reduced total sleep time among adolescents on weeknights, leading to less total sleep, as well as a link between lower sleep duration and poor mental health.
Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis
Leveraging Managed Care to Optimize Best Practices in the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Advances and Best Practices for Managed Care Pharmacists and the Treatment of Patients with Alpha-1 Antitrypsin Deficiency
Improving Outcomes and Quality of Care in Spinal Muscular Atrophy: Updates in Treatment Advances
New and Emerging Treatment Strategies for Myasthenia Gravis: The Role of the Specialty Pharmacist
Improving Treatment Access for Spinal Muscular Atrophy: How Managed Care Strategies Can Ease Clinical and Caregiver Burden
Assessing the Treatment Landscape for Multiple Sclerosis to Better Individualize Care
Exploring Transthyretin-Mediated Amyloidosis and Its Phenotypes: A Comprehensive Approach to Patient Treatment
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
Survey Finds Widespread Misconceptions About Sleep Disorders